Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
54°
Clear
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Gamida Cell Ltd
(NQ:
GMDA
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Apr 5, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Gamida Cell Ltd
< Previous
1
2
3
Next >
Gamida Cell Initiates Rolling Submission of Biologics License Application for Omidubicel
February 09, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Announces Appointment of Anat Cohen-Dayag and Naama Halevi-Davidov to its Board of Directors
January 31, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Provides Key Program Updates and 2022 Financial Guidance
January 31, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Ltd. (NASDAQ:GMDA) Investor Alert: Investigation over Potential Wrongdoing
January 27, 2022
San Diego, CA -- (SBWIRE) -- 01/27/2022 -- Certain directors of Gamida Cell Ltd are under investigation over potential breaches of fiduciary duties.
Via
SBWire
Gastrointestinal Cancer Treatment Trials Driven by Rising Incidences of Colorectal Cancer
January 20, 2022
Palm Beach, FL – January 20, 2022 – FinancialNewsMedia.com News Commentary – Despite significant progress in the treatment of gastric cancer, it is still among the leading causes of deaths due to...
Via
FinancialNewsMedia
Topics
Death
Exposures
Death
Gamida Cell Provides Update on Omidubicel BLA Submission
January 19, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Announces Data to be Presented at 2022 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR Tandem Meetings
January 07, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Ltd. (NASDAQ:GMDA) Shareholder Alert: Investigation over Possible Violations of Securities Laws
December 13, 2021
San Diego, CA -- (SBWIRE) -- 12/13/2021 -- Gamida Cell Ltd is under investigation over potential securities laws violations in connection with certain financial statements.
Via
SBWire
Exposures
Product Safety
Gamida Cell Presents Two-Year Survival Data for GDA-201 and Resource Utilization Analysis for Omidubicel at 63rd ASH Annual Meeting
December 13, 2021
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Presents New Omidubicel Data at 63rd ASH Annual Meeting
December 11, 2021
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell to Present Corporate Highlights at Multiple Upcoming Investor Conferences
November 16, 2021
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Reports Third Quarter 2021 Financial Results and Provides Company Update
November 15, 2021
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Provides Update on Pre-BLA Meeting With FDA for Omidubicel
November 11, 2021
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Presents New Data on Nicotinamide-Enabled NK Cell Therapy at Society for Immunotherapy of Cancer's (SITC) 36th Annual Meeting
November 09, 2021
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Announces the Date of Its Third Quarter 2021 Financial Results and Webcast
November 08, 2021
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Announces Data to Be Presented at 63rd ASH Annual Meeting
November 04, 2021
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Presents Data on its NAM-Enabled NK Cell Therapies at Protein & Antibody Engineering Summit (PEGS) Europe
November 04, 2021
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell to Present NAM-Enabled, Genetically Modified NK Cell Therapy Pipeline and Update on GDA-201 at Today’s Virtual R&D Day
October 26, 2021
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell to Present at Society for Immunotherapy of Cancer's (SITC) 36th Annual Meeting
October 19, 2021
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell to Host Virtual Event Highlighting GDA-201 and NAM-Enabled, Genetically Modified NK Cell Therapy Pipeline
September 28, 2021
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell to Present Corporate Highlights at Multiple Investor Conferences in September
September 02, 2021
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Reports Second Quarter 2021 Financial Results and Provides Company Update
August 11, 2021
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Announces the Date of Its Second Quarter 2021 Financial Results and Webcast
August 04, 2021
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell to Present at the BTIG Virtual Biotechnology Conference
August 03, 2021
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Announces Publication in Blood, the Journal of the American Society of Hematology, of the First Pivotal Trial to Evaluate a Cell Therapy (Omidubicel) for Patients with Blood Cancer who Require an Allogeneic Stem Cell Transplant
June 23, 2021
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell to Present Corporate Highlights at Multiple Investor Conferences in June
June 09, 2021
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Announces Appointment of Senior Vice President, Global Operations and Manufacturing and Provides Commercial Manufacturing Update
June 07, 2021
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell to Present at the RBC Capital Markets Global Healthcare Conference
May 12, 2021
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Reports First Quarter 2021 Financial Results and Provides Company Update
May 11, 2021
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Announces the Date of Its First Quarter 2021 Financial Results and Webcast
May 04, 2021
From
Gamida Cell Ltd.
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.